Navigation Links
Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
Date:9/28/2007

Study Reveals that Thoracic Endoluminal Grafting is a Feasible Alternative

TO Open Surgical Repair J Vasc Surg. 2007 Sep; 46(3):413-20. Application of Endograft to Treat Thoracic Aortic Pathologies: A Single Center Experience. Rodriguez JA, Olsen DM, Shtutman A, Lucas LA, Wheatley G, Alpern J, Ramaiah V, Diethrich

EB.

PHOENIX, Sept. 28 /PRNewswire/ -- The Arizona Heart Institute announced today that results from its single-center study of the effectiveness of endoluminal grafting for thoracic aortic pathologies were published in the September 2007 issue of the Journal of Vascular Surgery. Presented in the leading subspecialty, peer-reviewed journal in the field of vascular surgery, the study showed that patients with potentially life-threatening conditions of the thoracic aorta, including thoracic aortic aneurysms, can be treated effectively using a less invasive method associated with minimal blood loss, faster recovery, shorter hospital stays and decreased risk of death.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/arizonaheartinstitute/29934/

"This study represents a significant milestone in managing complex conditions of the thoracic aorta," reported Julio A. Rodriquez-Lopez, M.D., lead author and medical director of Peripheral Vascular Services at the Arizona Heart Institute. "In our research findings and overall experience with thoracic endoluminal graft (ELG) repair, we see a significantly less overall complication rate, including death, compared to published adverse events associated with open surgical repair," continued Rodriguez. "This is greatly due to the minimally invasive nature of the technique as well as our ability to proactively treat patients with elective, non-emergent procedures earlier in the disease process."

Thoracic aortic aneu
'/>"/>

SOURCE The Arizona Heart Institute
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
2. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
3. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
4. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
5. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
6. Drug for Treatment of Heart Failure Does Not Improve Survival, Compared to More Widely-used Medication
7. deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
8. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
9. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
10. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2008)...- Bayer together with Nektar Therapeutics present ... treatment of pneumonia in intubated and ...TO and BERLIN, May 19 /- Ba...Nasdaq: NKTR ), today presented positive,prelimin...ination Amikacin,Inhale at the American Thoracic S...
(Date:5/19/2008)... - RDEA594 Data to Be Presented at the 2008 Annu... the European League Against Rheumatism (EULAR) -,...lanned in Second Half of ...tCall/ -- Ardea Biosciences, Inc.,(Nasdaq: RDEA )...velopment,candidate for the treatment of patients ...
(Date:5/19/2008)... MARSEILLE, France, May 19 /- IPSO...r that develops and markets molecular diagnostic,a...that researchers from,the University of Texas MD A...esent the results of two studies on the Genomic Gr...n Chicago from May 30 to June 3, 2008. The data,in...
(Date:5/18/2008)... -- Additional Data Demonstrated Higher Overall...and Symptom Relief versus Placebo --, SAN DIEGO, ... Inc.,today reported results from three pivotal Ph...TAK-390MR, the first proton pump inhibitor (PPI),w... in healing patients,with erosive esophagitis (EE)...
Breaking Medicine Technology:Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 3Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 4Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 5Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 2Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 3Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 4TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 2TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 3TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 4Isis Pharmaceuticals and Thomas McNerney 26 Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory 1281 1Isis Pharmaceuticals and Thomas McNerney 26 Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory 1281 2Isis Pharmaceuticals and Thomas McNerney 26 Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory 1281 3Isis Pharmaceuticals and Thomas McNerney 26 Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory 1281 4Isis Pharmaceuticals and Thomas McNerney 26 Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory 1281 5Rigel to Present Research Programs at Scientific Conferences 1279 1Rigel to Present Research Programs at Scientific Conferences 1279 2Rigel to Present Research Programs at Scientific Conferences 1279 3Targeted Nanoparticles Offer Promise in the Battle Against Cancer 529 1Targeted Nanoparticles Offer Promise in the Battle Against Cancer 529 2Why Healthy People Should Consider Individual Disability Insurance 3762 1Why Healthy People Should Consider Individual Disability Insurance 3762 2
(Date:5/20/2008)...sed skin health program, the first of its kind, ad...es affecting an increasingly diverse,America, airi...ay 24, 2008., SAN FRANCISCO, May 20 /PRNewswire/ ...esigned to educate and inform the public about the...omen,s Dermatologic Society (WDS),is pleased to an...
(Date:5/20/2008)... C is a health care problem all over the world, wi...he treatment is expensive and has variable results... The first land mark in treatment is the virus cle...tment Response (ETR), but many of the patients ach...months. Thus, the goal of treatment is to have per...
(Date:5/20/2008)...s to Aid America,s Wounded Warriors Facing Combat-... with Traumatic Brain Injury, WASHINGTON, May 20 ...elated vision loss have been among the most common...airmen and Marines serving in Iraq and,Afghanistan...er in,Washington, D.C., U.S. Rep. John Boozman, O....
(Date:5/20/2008)...ew England,s largest fertility clinics expands to ...e/ -- Reproductive Science Center,(RSC) of New Eng...kind,nationwide, announces a new partnership with ...ertility clinic at the hospital,s satellite facili... 250., Dr. Ania Kowalik, board-certified reproduc...
Breaking Medicine News(10 mins):Health News:Women's Dermatologic Society Announces Collaboration on 'America's Ethnic Skin: An Al Roker Health Special' 2Health News:Women's Dermatologic Society Announces Collaboration on 'America's Ethnic Skin: An Al Roker Health Special' 3Health News:Rep. Boozman, AOA Officials Tour Military Eye Care Facilities at Walter Reed Army Medical Center 2Health News:Rep. Boozman, AOA Officials Tour Military Eye Care Facilities at Walter Reed Army Medical Center 3Health News:Rep. Boozman, AOA Officials Tour Military Eye Care Facilities at Walter Reed Army Medical Center 4Health News:Reproductive Science Center and Lowell General Hospital Announce Partnership in Infertility Treatment 2
... to explore the relationship between bicycle ridin...phasized whether or not a causal relationship exis... erectile dysfunction (disease). // However, it is...on according to Dr. Schrader, an expert in the fie...
...ata, not even sparing the city's upscale neighbour...ee has admitted that the fever that swept through ...fever. There have been reports of 4 casualties and...e of dengue in eight other people. The unofficial ...
... continues to daily kill a few more people in Utta...ring areas like Nepal. In this special report we r...ain fever and provide some essential information o... its life cycle and prevention. The first histo...
...mising with the life of its patients and selling e...ispensary says a latest report. The criminal opera...h exposed and captured unethical conduct on camera...those involved first went into denial mode immedia...
Other Medicine News:Health News:Brain Fever or Encephalitis Spreading in North India 2
...e beyond your investment., ,The Centiva/5 Critica...d time demands of the critical care environment. T... mind combining a compact size with high levels of...uable space around the patients bed and allows you...
...ther treatments for ,ED (e.g. Viagra, Injections...,Vacuum Therapy is gaining increasing ,popul...of the very positive associated benefits. ,In fa...ercise to prevent atrophy and to promote penile he...
...Mesh LP Self-Forming Plug is combining a lightweig... This results in a very soft hernia plug which sta...rd Plugs less foreign body material is included in... hernia size and shape allows for a softer and les...
...Mesh Self-Forming Plug is a mesh plug to treat lar...l hernias and femoralhernias. The self-expanding p...mpletely. Premilene Mesh Self-Forming Plug is a pr...h. The plug corresponds with all properties of Pre...
Medicine Products: